Italia markets close in 1 hour 7 minutes

FTSE MIB
34.536,08
-288,93(-0,83%)
Dow Jones
39.870,23
+63,46(+0,16%)
Nasdaq
16.764,19
-30,68(-0,18%)
Nikkei 225
38.946,93
-122,75(-0,31%)
Petrolio
78,95
-0,85(-1,07%)
Bitcoin EUR
65.040,62
+3.352,47(+5,43%)

NVCR Jan 2025 30.000 put

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

17,42

0,00

(0,00%)

In data: 10:56AM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in